Health
Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy – News-Medical.Net
Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas….
Chimeric antigen receptor T-cell therapy, or CAR T, is a relatively new type of therapy approved to treat several types of aggressive B cell leukemias and lymphomas. Many patients have strong responses to CAR T; however, some have only a short response and develop disease progression quickly. Unfortunately, it is not completely understood why these patients have progression. In an article published in Proceedings of the Royal Society B, Moffitt Cancer Center researchers use mathematical modeling…
-
Noosa News23 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
Noosa News14 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General8 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
General10 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for